Velo3D Offers Industry Leading Metal 3D Printing Services

Velo3D

Velo3D

Velo3D is a premier provider of metal 3D printing services and offers metal additive manufacturing for various industries.

CAMPBELL, CA, UNITED STATES, July 15, 2019 /EINPresswire.com/ — 3D printing has taken the world by storm in recent years. Not only has it led to unprecedented medical breakthroughs, but it has also forever changed the manufacturing industry as a whole. Highly specialized metal 3D printing allows manufacturers the opportunity to create parts and components that were once deemed impossible due to the limitations of technology. Velo3D is a premier provider of metal additive manufacturing services for a wide variety of industries, and the company’s combination of equipment and software is the best of its kind.

Sapphire is a next-generation laser fusion metal additive manufacturing system that allows for the world’s t advanced 3D metal printing. Conventional metal printers are limited to creating objects with angles of greater than 45 degrees, and they require supports for creating angles below this. However, with Sapphire from Velo3D, it is possible to create pieces with overhangs lower than 10 degrees – including large inner diameters – all without the need for such supports. Velo3D designed sapphire with high-volume production in mind, too, which makes it perfect for a variety of industries reliant upon metal components and parts.

Flow software is designed to work alongside the Sapphire metal additive manufacturing system to provide predictable results with fewer errors and a shorter-than-average print preparation time. Flow is different because of its integrated simulation engine that allows engineers to predict the outcomes of even the most cumbersome processes. It is backed in Computer Aided Design (CAD) but introduces a relatively simple and intuitive user interface that makes design a snap.

The simulation engine can even make automatic corrections to help avoid deformation and other issues before the printing process even starts, which means components come out right the first time. Finally, Flow’s built-in and highly useful Composer accurately detects geometric features and helps to optimize the print process around them, which results in more predictability. Though much of this process is automated, users can easily review the recommended processes, laser assignment, and layer order (in two or three dimensions), then make corrections so the printer makes very specific movements.

To learn more about Velo3D’s metal additive manufacturing capabilities through Sapphire, Flow, or a combination of the two, visit their website or send them an email at info@velo3D.com. You can also telephone (408)610-3915 or fill out the short contact form online for more information.

About the Company: Velo3D is a California-based business that specializes in designing and developing high-tech metal additive manufacturing solutions. Their goal involved creating an entirely new approach to metal 3D printing, which would then drive manufacturers to see its value – and reap its benefits. Today, Velo3D’s Sapphire and Flow technology are at the heart of many manufacturing companies across the globe, and more manufacturers discover the power and technology behind 3D printing every single day. Velo3D delivers the future in a user-friendly package that will forever change the way companies manufacture their components. For more information please visit http://www.velo3d.com/.

Velo3D
Velo3D
+ 1 (408) 610-3915
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

CEA Opioid Task Force to Announce Role in National Opioid Litigation and Class Action Settlement Initiative

County Executives of America Opioid Task Force has Pushed Forward with Litigation Against the Opioid Industry.

WASHINGTON, DISTRICT OF COLUMBIA, UNITED STATES, July 15, 2019 /EINPresswire.com/ — On July 18, 2019 at 2:00 p.m. E.S.T at the National Press Club in Washington, D.C., the Chairman of the County Executives of America (CEA) Opioid Task Force and Albany County, NY County Executive, Dan McCoy, will announce the role the CEA has played in the national opioid litigation, why municipalities are involved in the litigation and why the litigation is critical to securing the aid so many of the country’s municipalities need.

Over the last two and a half years, the task force has pushed forward with litigation against the opioid industry and worked with legal counsel to provide input to legal counsel for issues they encounter in their communities related to the opioid epidemic and their goals in bringing the litigation, including reform suggestions to help prevent future similar epidemics and what types of potential resolutions would be most beneficial. Leadership from the CEA Opioid Task Force also is serving as a class representative in the proposed Negotiation Settlement Class, an innovative class action approach with the goal of encouraging settlement negotiations with defendants.

Counties are some of the hardest hit municipalities in the U.S. and are on the front lines in responding to the epidemic as they provide essential community services such as emergency services and child welfare care. Such services and County personnel have shouldered the burden in providing for their residents. During the press conference, the leaders of the task force will be present to highlight the dilemma of counties.

Additionally, Motley Rice LLC co-founder, CEA Opioid Task Force Counsel and one of the co-leads for the National Prescription Opiate Multidistrict Litigation, Joe Rice, will discuss the current status of the opioid litigation. He will also provide details about the proposed Negotiating Class that would create a cohesive group of cities, counties, towns, parishes, villages and boroughs for the sole purpose of negotiating a settlement with opioid defendants, plaintiffs in the National Prescription Opiate Multidistrict Litigation.

For more information contact:

Michael Griffin
County Executives of America
+1 202-628-3585
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

HIV: holes in the immune system left unrepaired despite drug therapy

A discovery by CRCHUM researchers paves the way to new therapies that might complement antiretroviral therapy.

MONTREAL, QUEBEC, CANADA, July 15, 2019 /EINPresswire.com/ — If they don’t receive antiretroviral therapy (ART), most HIV patients see a progressive weakening of their immune system. But a very small percentage of patients—0.3%—spontaneously control the virus themselves, without ART. Could an explanation lay partly in the sets of genes expressed by scarce white blood cells that recognize HIV? Yes, according to a study published in Nature Immunology and conducted by researchers at the University of Montreal Hospital Research Centre (CRCHUM).

Critical for the coordination of immune responses, CD4 T cells are important white blood cells (lymphocytes) that help control chronic infections like HIV. But on average only about one cell in 1,000 in the CD4 T cell population can recognize the virus.

“With my research team and my collaborators, we comprehensively determined the entire set of genes expressed by these rare cells from the blood of people chronically infected with HIV in whom the virus was abundant prior to ART,” said Daniel Kaufmann, a CRCHUM researcher and an infectious disease specialist. “We then compared it to the cells of HIV controllers, infected people who control the virus in the absence of therapy. This type of powerful approach, also called genome-wide transcriptional profiling, measures the activity of thousands of genes at once, thus creating a global picture of cellular function.”

Using sophisticated cell analysis techniques, lead author Antigoni Morou, a postdoctoral fellow in Kaufmann’s lab, identified major functional differences between the two groups of patients in the study. The HIV controllers had much more robust immune responses, known as Th17 and Th22, which are important for the defence of the gastrointestinal tract, for example. But chronically infected patients with high levels of viral replication showed dysregulated CD4 T cells targeting HIV, and some of their cell subsets showed signs of abnormal functioning.

New therapies ahead?

Continuing their investigation, the CRCHUM scientists wondered whether ART leads to an immune response akin to the one found in HIV controllers. “We followed up chronically infected patients after control of the virus by ART and checked if the treatment can ‘repair their immune system’ and allow them to have CD4 T cells with features similar to those of the HIV controllers,” said Kaufmann, a professor at Université de Montréal.

The result was double-edged: some gene modules were sensitive to ART, while others turned out to be expressed very differently than in HIV controllers.

“We showed that ART leaves unrepaired holes in the immune system’s wall of defence,” said Kaufmann. “Our results suggest that some of these long-lasting defects may contribute to the lack of viral control once the antiretroviral therapy is interrupted. We now know which holes linger in the immune system. Do we have to fill them in, and if so, how? This is another science question.”

Paving the way to new therapies that could complement ART, Kaufmann’s team identified important features of an effective HIV specific immune response compared to a dysfunctional one and showed how the response can be affected by ART.

The next step will be to study the underlying programming of these CD4 T cells (epigenetics) in the hope of developing new targeted strategies to reverse immune dysfunction and complement ART. Kaufmann’s lab is now using the same approach to evaluate candidates for an HIV vaccine. In 2017, nearly 37 million people were living with HIV. Every day, 5,000 new infections are reported to health authorities around the world.

– 30 –

About this study

“Altered differentiation is central to HIV-specific CD4+ T cell dysfunction in progressive disease” by Antigoni Morou et al. was published July 15, 2019 in Nature Immunology. The research was funded by the US National Institutes of Health; the Canadian Institutes of Health Research; the AIDS and Infectious Diseases Network of the Fonds de Recherche du Québec-Santé; and a Canada Foundation for Innovation Program Leader grant.

About the CRCHUM

The University of Montreal Hospital Research Centre (CRCHUM) is one of North America’s leading hospital research centres. It strives to improve adult health through a research continuum covering such disciplines as the fundamental sciences, clinical research and public health. Over 1,861 people work at the CRCHUM, including 542 scientists and 719 students and research assistants. chumontreal.qc.ca/crchum @CRCHUM

About Université de Montréal

Deeply rooted in Montreal and dedicated to its international mission, Université de Montréal is one of the top universities in the French-speaking world. Founded in 1878, Université de Montréal today has 16 faculties and schools, and together with its two affiliated schools, HEC Montréal and Polytechnique Montréal, constitutes the largest centre of higher education and research in Québec and one of the major centres in North America. It brings together 2,500 professors and researchers and has more than 60,000 students. umontreal.ca

Joelle Lachapelle
University of Montreal Hospital (CHUM)
+1 514-890-8000
email us here


Source: EIN Presswire

Hematocrit Test Industry – Treatment, Outlook, Analysis, Research, Review to 2023

WiseGuyReports.Com Publish a New Market Research Report On –“ Hematocrit Test Industry – Treatment, Outlook, Analysis, Research, Review to 2023”.

PUNE, INDIA, July 15, 2019 /EINPresswire.com/ —

Hematocrit Test Industry 2019

Description:-

This report analyzes the global hematocrit test market by product (analyzer, hematocrit test meter), indication (anemia, leukemia, lymphoma, congenital heart disease, kidney tumor), end-user (hospital, clinic, diagnostic center); it also studies the top manufacturers in the market.
The global hematocrit test market is expected to grow at a CAGR of 4.5% during the forecast period.

Get a Free Sample Report @ https://www.wiseguyreports.com/sample-request/4201927-hematocrit-test-market-research-report-forecast-till-2023

For more information or any query mail at sales@wiseguyreports.com

The major players in global hematocrit test market include:
• Abbott (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Siemens AG (Germany)
• Beckman Coulter, Inc. (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• Horiba, Ltd. (Japan)
• Mindray Medical International Limited (China)
• Boule Diagnostics AB (Sweden)
• Nihon Kohden Corporation (Japan)
• Sysmex Corporation (Japan)

The market revenue and share have been analyzed with respect to the following regions and countries:
America
North America
U.S.
Canada
South America
Europe
Western Europe
Germany
France
Italy
Spain
U.K.
Rest of Western Europe
Eastern Europe
Asia Pacific
China
India
Japan
Australia
Republic of Korea
Rest of Asia Pacific
The Middle East & Africa
United Arab Emirates
Saudi Arabia
Oman
Kuwait
Qatar
Rest of the Middle East & Africa

On the basis of product, the global hematocrit test market has been categorized into the following segments:

• Analyzer
• Hematocrit Test Meter

On the basis of indication, the global hematocrit test market has been categorized into the following segments:
• Anemia
• Leukemia
• Lymphoma
• Congenital Heart Disease
• Kidney Tumor

On the basis of end user, the global hematocrit test market has been categorized into the following segments:
• Hospital
• Clinic
• Diagnostic Center

Ask Query @ https://www.wiseguyreports.com/enquiry/4201927-hematocrit-test-market-research-report-forecast-till-2023

Research Methodology

The analysis is conducted by industry experts who offer insight into industry structure, market segmentation, technology assessment, competitive landscape (CL), and market penetration, as well as on emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on years of professional expertise in their respective industries. Our analysts also predict where the market will be headed in the next five to 10 years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories in different regions are estimated based on primary and secondary research.

Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets. The key players in the market were identified through secondary research, and their market contributions in the respective regions were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis by Researcher added before being presented in this report.

Table Of Content – Major key Points

1. Report Prologue

2. Market Introduction

3. Research Methodology

4. Market Dynamics

5. Market Factor Analysis

6. Global Hematocrit Test Market, By Product

7. Global Hematocrit Test Market, By Indication

8. Global Hematocrit Test Market, By End User

9. Global Hematocrit Test Market, By Region

Continued……

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
646 845 9349 / +44 208 133 9349
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Jahn H. Oppenheimer, DDS, FICOI, FIDIA Listed as Best for Cosmetic, Family & Implant Dentistry

Jahn H. Oppenheimer, DDS, FICOI, FIDIA

Coral Gables, Florida Dentist Selected to the "America's Best Dentists" 2019 Directory

Dr. Jahn H. Oppenheimer listed as Best for Implant, Cosmetic & Family Dentistry”

— TodaysBestDentists.com

CORAL GABLES, FLORIDA, UNITED STATES, July 15, 2019 /EINPresswire.com/ — Coral Gables, Florida dentist, Jahn H. Oppenheimer DDS, FICOI, FIDIA has been selected to the "America's Best Dentists" registry for 2019. Selections were made by the National Consumer Advisory Board, an organization that identifies top professionals in their fields.

Dr. Oppenheimer practices Cosmetic, Family & Implant Dentistry with Dental Associates of South Florida, 30 Miracle Mile in Coral Gables. He treats patients in Dade County, South East Florida, Miami, South Miami, Pinecrest, Coral Gables, and Kendall.

Services include: Cosmetic Dentistry, General Dentistry, Dental Implants, Endodontics (Root Canals), Prosthodontics (Crowns, Bridges & Veneers), Periodontal Treatment for Gum Disease, Dentures, Partial Dentures, Children’s Dentistry, Extractions, Bone Grafts, Tooth Whitening and Dental Emergency Care.

Dr. Oppenheimer received his Doctor of Dental Surgery degree (DDS) from Marquette University. During his 30 years in practice, he has been extremely active in continuing education. Dr. Oppenheimer has been awarded prestigious fellowship status by The International Congress of Oral Implantologists and Mastership honors by the American Dental Implant Association.

For more information, please go to www.TodaysBestDentists.com or contact Dr. Jahn H. Oppenheimer directly at 305-448-7778.

The "National Consumer Advisory Board" accepts no fees, sponsorships, donations or advertising in their selection process. Dentists were chosen following an application based on training, experience, continuing education, and dedication to excellence. Only Dentists that satisfy all the board's criteria can qualify for inclusion in the "Americas Best Dentists" directory.

TodaysBestDentists.com
Americas Best Dentists
+1 475-282-3043
email us here


Source: EIN Presswire

Hemophilia Treatment Industry – Treatment, Outlook, Analysis, Research, Review to 2023

WiseGuyReports.Com Publish a New Market Research Report On –“ Hemophilia Treatment Industry – Treatment, Outlook, Analysis, Research, Review to 2023”.

PUNE, INDIA, July 15, 2019 /EINPresswire.com/ —

Hemophilia Treatment Industry 2019

Description:-

This report analyzes the global hemophilia treatment market by type (hemophilia A, hemophilia B, hemophilia C), by treatment (recombinant coagulation factor, plasma-derived coagulation factor, desmopressin, antifibrinolytic agents), end user; it also studies the top manufacturers in the market.
The global hemophilia treatment market is expected to grow at a CAGR of approximately 6.10% during the forecast period 2018 – 2023.

Get a Free Sample Report @ https://www.wiseguyreports.com/sample-request/4201930-hemophilia-treatment-market-research-report-forecast-to-2023

For more information or any query mail at sales@wiseguyreports.com

The major players in global hemophilia treatment market include:
• F.Hoffmann-La Roche Ltd
• Octapharma
• CSL Behring
• Kedrion
• Sanofi
• Bayer AG
• Baxter
• Swedish Orphan Biovitrum AB
• Grifols International S.A
• Shire
• Pfizer Inc
• Novo Nordisk A/S.

The market revenue and share have been analyzed with respect to the following regions and countries:
America
North America
U.S.
Canada
South America
Europe
Western Europe
Germany
France
Italy
Spain
U.K.
Rest of Western Europe
Eastern Europe
Asia Pacific
China
India
Japan
Australia
Republic of Korea
Rest of Asia Pacific
The Middle East & Africa
United Arab Emirates
Saudi Arabia
Oman
Kuwait
Qatar
Rest of the Middle East & Africa

On the basis of type, the global hemophilia treatment market has been categorized into the following segments:

• Hemophilia A
• Hemophilia B
• Hemophilia C

On the basis of treatment, the global hemophilia treatment market has been categorized into the following segments:
• Recombinant Coagulation Factor
• Plasma-Derived Coagulation Factor
• Desmopressin
• Antifibrinolytic Agents

On the basis of end-user, the global hemophilia treatment market has been categorized into the following segments:
• Hospitals & Clinics
• Research Organizations
• Others

Ask Query @ https://www.wiseguyreports.com/enquiry/4201930-hemophilia-treatment-market-research-report-forecast-to-2023

Research Methodology

The analysis is conducted by industry experts who offer insight into industry structure, market segmentation, technology assessment, competitive landscape (CL), and market penetration, as well as on emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on years of professional expertise in their respective industries. Our analysts also predict where the market will be headed in the next five to 10 years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories in different regions are estimated based on primary and secondary research.

Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets. The key players in the market were identified through secondary research, and their market contributions in the respective regions were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis by Researcher added before being presented in this report.

Table Of Content – Major key Points

Chapter 1. Report Prologue

Chapter 2. Market Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global Hemophilia Market, By Type

Chapter 8. Global Hemophilia Market, By Treatment

Continued……

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
646 845 9349 / +44 208 133 9349
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Global Surgical Suction Pumps Market Advancement,Growth Rate,Outlook Analysis 2019-2025

PUNE , MAHARASHTRA , INDIA , July 15, 2019 /EINPresswire.com/ — Surgical Navigation System can offer the patient preoperative or intraoperative image data and the operative bed patient's anatomical structure corresponding accurate, operation tracking of surgical instruments and the position of the surgical instrument in the patient image in real-time updates on the form of the virtual probe display, make the doctor of surgical instruments relative to patient anatomy structure at a glance, make surgery more rapid, more accurate and safer.

A study of the key drivers of the Surgical Navigation System market is available for keeping the players ahead of the curve. Also, the report sheds light on the threats and restraints that can pose challenges to the market participants. It also analyses the magnitude of the factors anticipated to affect the future trajectory of the market in the years to come.

Request Free Sample Report at: https://www.wiseguyreports.com/sample-request/3570750-global-surgical-navigation-systems-market-study-2015-2025

The historical trajectory of the Surgical Navigation System market is examined in the report in order to provide a basis for predictions regarding the market’s growth rate over the forecast period. Happenings in the Surgical Navigation System market in the review period are examined carefully to explain their connection with the market’s present state and future growth prospects.

The global Surgical Navigation Systems market will reach xyz Million USD in 2018 and with a CAGR if xx% between 2019-2025.

Surgical Navigation Systems Market Segmentation by Product Type

Optical Surgical Navigation Systems
Electromagnetic Surgical Navigation Systems
Other

Surgical Navigation Systems Market Segmentation by Application
Neurosurgery Surgery
Spinal Surgery
Orthopedic Surgery
ENT Surgery
Other

Major Key Players mentioned in this Industry

Medtronic
Stryker
GE Healthcare
Brainlab
B. Braun
Johnson & Johnson
Karl Storz
Zimmer Biomet
Fiagon
XION
Collin Medical
Anke
Fudan Digital Medical

Regional Analysis
North America
Europe
Asia-Pacific
South America
Middle East & Africa

Key Questions answers in this research report
1. What will be the Surgical Navigation System market size in 2025?
2. How will the market change over the forecast period.?
3. What are the threats and challenges in front of the businesses?
4. Who are the highest competitors in the global market?
5. Which factors are responsible for driving the global market?

View Detailed research report @ https://www.wiseguyreports.com/reports/3570750-global-surgical-navigation-systems-market-study-2015-2025

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

NORAH TRENT
Wise Guy Reports
841-198-5042
email us here
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}
["facebook", "twitter", "linkedin"]


Source: EIN Presswire

Washington Mesothelioma Victims Center Now Offers a New Service for a Person with Mesothelioma in Washington State to Ensure They Talk to Attorney Erik Karst of Karst von Oiste for Expedited Compensation

"We want to make certain a person with mesothelioma anywhere in the State of Washington receives the very best possible financial compensation results." ”

— Washington Mesothelioma Victims Center

SEATTLE, WA, USA, July 15, 2019 /EINPresswire.com/ — The Washington Mesothelioma Victims Center says, "We want to make certain a person with mesothelioma anywhere in the State of Washington receives the very best possible financial compensation results and to get the financial compensation job done we have endorsed attorney Erik Karst of the law firm of Karst von Oiste. If you or your family member has just been diagnosed with mesothelioma, please call us at 800-714-0303 so we can put you in direct contact with Erik Karst or his amazing colleagues at Karst von Oiste.

"One thing we are certain Erik would like to discuss is expedited financial compensation where it takes months not years to get compensated. How many mesothelioma Internet ads talk about possible expedited compensation? We are pretty certain Erik Karst and his colleagues at Karst von Oiste will be eager to talk about possible expedited mesothelioma compensation as we would like to discuss anytime at 800-714-0303." https://Washington.MesotheliomaVictimsCenter.Com

The Washington Mesothelioma Victims Center is an advocate for people in Washington State with mesothelioma and they want to make certain a diagnosed US Navy Veteran, a manufacturing worker, a power plant worker, or an industrial trades worker like a plumber, welder, construction worker has on the spot access to the nation’s most skilled and experienced mesothelioma lawyers as they would like to explain anytime at 800-714-0303. It is for this reason they have endorsed the law firm of Karst von Oiste. www.karstvonoiste.com/

The Washington Mesothelioma Victims Center wants to emphasize their services are available statewide in every community in Washington including Seattle, Tacoma, Spokane, Everett, Vancouver, Yakima, Bellingham, Aberdeen, Bremerton, Moses Lake, Chehalis, Olympia, Mount Vernon, Wenatchee, the Tri Cities, etc. www.karstvonoiste.com/

For the best possible mesothelioma treatment options in Washington the Washington Mesothelioma Victims Center strongly recommends the following heath care facility with the offer to help a diagnosed victim, or their family get to the right physicians at this treatment facility. The Center believes this treatment facility for mesothelioma to be one of the best in the nation. Fred Hutchinson Cancer Research Center and the UW Medical Center called the Seattle Cancer Care Alliance, in Seattle, Washington: https://www.uwmedicine.org/services/cancer-care

High-risk work groups for exposure to asbestos in Washington State include Veterans of the US Navy, hydro-electric power plant workers, shipyard workers, nuclear power plant workers, oil refinery workers, pulp and paper mill workers, factory workers, plumbers, electricians, miners, auto mechanics, machinists, and construction workers. Typically, the exposure to asbestos occurred in the 1950's, 1960's, 1970's, or 1980's. https://Washington.MesotheliomaVictimsCenter.Com

The states indicated with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon. www.karstvonoiste.com/

For more information about mesothelioma please refer to the National Institutes of Health's web site related to this rare form of cancer: https://www.cancer.gov/types/mesothelioma.

Michael Thomas
Washington Mesothelioma Victims Center
+1 800-714-0303
email us here


Source: EIN Presswire

Maine US Navy Veterans Mesothelioma Advocate Now Appeals to A Navy Veteran with Mesothelioma in Maine to Avoid Internet Lawyer Roulette and To Call Them for Direct Access to Attorney Erik Karst-Get Better Compensation

To get the financial compensation job done for a Navy Veteran with mesothelioma in Maine the Maine US Navy Veterans Mesothelioma Advocate has endorsed the remarkable law firm of Karst von Oiste.”

— Maine US Navy Veterans Mesothelioma Advocate

BANGOR , MAINE, USA, July 15, 2019 /EINPresswire.com/ — The Maine US Navy Veterans Mesothelioma Advocate says, "We are appealing a Navy Veteran with mesothelioma in Maine or their family members to call us anytime at 800-714-0303 to ensure they do not play Internet lawyer roulette. We are part of the nation's top advocacy group for Navy Veterans with mesothelioma in Maine and nationwide and our top goal is doing everything possible to make certain people like this receive the very best possible financial compensation results. We also offer a host of free services to assist a Navy Veteran dealing with this rare cancer caused my asbestos exposure." https://Maine.USNavyMesothelioma.Com

To get the financial compensation job done for a Navy Veteran with mesothelioma in Maine the Maine US Navy Veterans Mesothelioma Advocate has endorsed the remarkable law firm of Karst von Oiste and their founding partner Erik Karst. Erik Karst and his amazing partners at Karst von Oiste have been assisting Navy Veterans with mesothelioma for a generation. The group is urging a Navy Veteran with mesothelioma or their family to call them anytime at 800-714-0303 for direct access to attorney Erik Karst. www.karstvonoiste.com/

The Maine US Navy Veterans Mesothelioma Advocate is offering the following free services to a Navy Veteran in Maine-or their family members:

* Assistance in discovering the best possible treatment options for the US Navy Veteran

* Advising the family on how best to take care of their loved one

* On the spot access to attorney Erik Karst of the law firm of Karst von Oise for the best possible compensation results. https://Maine.USNavyMesothelioma.Com

The US Navy Veterans Mesothelioma Advocate offers their free services to US Navy Veterans with mesothelioma in Portland, Lewiston, Bangor or anywhere in or anywhere in Maine.

For the best possible mesothelioma treatment options in Maine the Maine US Navy Veterans Mesothelioma Advocate strongly recommends the following heath care facility with the offer to help a diagnosed victim, or their family get to the right physicians at this hospital.

* The Maine Medical Cancer Institute: https://www.mmc.org/cancer-institute

* The VA-For a state by state listing of VA Medical Centers nationwide please visit their website: https://www.va.gov/ directory/guide/FindLocations. cfm.

Every US Navy ship vessel built up to 1980 contained asbestos. Extreme exposure to asbestos may have occurred to US Navy Veterans if they were assigned to a navy ship’s engine room, as a machinists mate, electrician, plumber/pipefitter, mechanic, in engineering, as a repair crew member, as a crew member on a nuclear submarine or as a member of the Navy Seabees. Additionally, a US Navy Veteran could have received extreme exposure to asbestos if they were required to stay on their ship or submarine for a major repair, overhaul or retrofit at a shipyard. Asbestos exposure was so extreme on US Navy ships and submarines, about one third of all US citizens diagnosed with mesothelioma each year are Veterans of the US Navy. https:// USNavyMesothelioma.Com

The states with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon.

However, based on the calls the US Navy Veterans Mesothelioma advocate receives a US Navy Veteran diagnosed with mesothelioma could live in any state including New York, Florida, California, Texas, New Hampshire, Vermont, Iowa, Indiana, Missouri, Kentucky, Tennessee, North Carolina, Georgia, Alabama, Mississippi, Oklahoma, Arkansas, Nebraska, North Dakota, Montana, Wyoming, Colorado, Nevada, New Mexico, Utah, Arizona, Idaho, or Alaska. www.karstvonoiste.com/

For a listing of various classes of US Navy ships or submarines please visit the US Navy website on this topic: https://www.navy.mil/ navydata/our_ships.asp.

For more information about mesothelioma please refer to the National Institutes of Health’s web site related to this rare form of cancer: https://www.cancer.gov/types/mesothelioma.

Michael Thomas
Maine US Navy Veterans Mesothelioma Advocate
+1 800-714-0303
email us here


Source: EIN Presswire

Ginger Essential Oil Global Market Size, Share, Demand, Growth, Opportunities, Key Player & Forecast 2025

This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies

PUNE, INDIA, July 15, 2019 /EINPresswire.com/ — Ginger essential oil is extracted from the plant Zingiberaceae officinale of the Zingiberaceae family. This report mainly studies Ginger Essential Oil Extract market.

According to this study, over the next five years the Ginger Essential Oil market will register a xyz% CAGR in terms of revenue, the global market size will reach US$ xyz million by 2024, from US$ xyz million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Ginger Essential Oil business, shared in Chapter 3.

We conduct a highly comprehensive and consistent research methodology to garner the most precise estimates as well as forecasts about the market. We do this by curbing down the deviance. We utilize a combination of both top-down and bottom-up approaches for segmenting as well forecasting the quantitative areas of the global Ginger Essential Oil market. Add to this, the report was curated by undertaking data triangulation to grab a look over the market from three distinctive perspectives.

This report presents a comprehensive overview, market shares, and growth opportunities of Ginger Essential Oil market by product type, application, key manufacturers and key regions and countries.

This study considers the Ginger Essential Oil value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Organic
Conventional

Request a Free Sample Report @ https://www.wiseguyreports.com/sample-request/4221298-global-ginger-essential-oil-market-growth-2019-2024

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Food
Beverage
Pharmaceutical
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Kancor
Lala Jagdish Prasad&Co
SILVERLINE CHEMICALS
Avi Naturals
Aromaaz International
Jedwards International
SVA Organics
Ozone Naturals
PLAMED(CN)

The leading players operating in the Ginger Essential Oil market are also studied in the report to provide readers with a comprehensive overview of the competitive landscape in the market. The major strategies used by leading players in the Ginger Essential Oil market are studied in the report to provide readers with an idea of what works and what doesn’t, in the Ginger Essential Oil market. Individual players are analyzed in detail in the report in order to elaborate on their regional presence and product catalog, providing a clear overview of each major player operating in the Ginger Essential Oil market.

Table of Contents

2019-2024 Global Ginger Essential Oil Consumption Market Report

1 Scope of the Report

2 Executive Summary

3 Global Ginger Essential Oil by Manufacturers

4 Ginger Essential Oil by Regions

5 Americas

6 APAC

7 Europe

8 Middle East & Africa

9 Market Drivers, Challenges and Trends

10 Marketing, Distributors and Customer

11 Global Ginger Essential Oil Market Forecast

12 Key Players Analysis

13 Research Findings and Conclusion

……Continued

Access Complete Report @ https://www.wiseguyreports.com/reports/4221298-global-ginger-essential-oil-market-growth-2019-2024

NORAH TRENT
Wise Guy Reports
841-198-5042
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire